Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,207 | -7,367 | -23,361 | -18,926 | -12,404 |
| Depreciation Amortization | 69 | 29 | 1,976 | 1,706 | 1,074 |
| Accounts receivable | 34 | 76 | -106 | -134 | -125 |
| Accounts payable and accrued liabilities | -389 | -778 | 1,140 | 509 | 185 |
| Other Working Capital | 897 | 327 | 1,891 | 1,027 | 792 |
| Other Operating Activity | 3,509 | 3,272 | -2,196 | -1,303 | -2,011 |
| Operating Cash Flow | $-10,087 | $-4,442 | $-20,656 | $-17,123 | $-12,489 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | -14 | -12 | -12 |
| Net Acquisitions | -1,849 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-1,854 | $N/A | $-14 | $-12 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 17,250 | 17,250 | 17,250 |
| Common Stock Issued | 9,802 | 9,786 | 5 | N/A | 0 |
| Other Financing Activity | 10,026 | 10,026 | -1,202 | -1,202 | -1,160 |
| Financing Cash Flow | $19,828 | $19,812 | $16,053 | $16,048 | $16,090 |
| Beginning Cash Position | 3,311 | 3,311 | 7,927 | 7,927 | 7,927 |
| End Cash Position | 11,198 | 18,681 | 3,311 | 6,842 | 11,517 |
| Net Cash Flow | $7,887 | $15,370 | $-4,617 | $-1,086 | $3,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,087 | -4,442 | -20,656 | -17,123 | -12,489 |
| Capital Expenditure | -5 | N/A | -14 | -12 | -12 |
| Free Cash Flow | -10,092 | -4,442 | -20,670 | -17,134 | -12,501 |